EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti–β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C

Tessa Noordermeer, Soumaya Chemlal, Janna J Jansma, Vossa van der Vegte, Roger E G Schutgens, Maarten Limper, Philip G de Groot, Joost C M Meijers, Rolf T Urbanus

Journal of Thrombosis and Haemostasis · 2023-09 · 21 (9) · 2509-2518

DOI: 10.1016/j.jtha.2023.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-09. Verfasst von Tessa Noordermeer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Ne…. Hauptthemen laut MEDLINE: Activated Protein C Resistance, Antiphospholipid Syndrome, Autoantibodies, Factor V. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Trombosestichting Nederland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activated Protein C ResistanceAntiphospholipid SyndromeAutoantibodiesFactor VThrombosisHumansbeta 2-Glycoprotein ILupus Coagulation InhibitorPhosphatidylserinesProtein CProthrombin

Stichwörter der Autor:innen

activated protein C resistanceantiphospholipid antibodieslupus anticoagulantprothrombinβ2-glycoprotein I

Substanzen

Autoantibodiesbeta 2-Glycoprotein IFactor VLupus Coagulation InhibitorPhosphatidylserinesProtein CProthrombin

Autor:innen und Institutionen

  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Circulatory Health Research Center, University Medical Cent…
  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Synapse Research Institute, Maastricht, the Netherlands.
  • Department of Molecular Hematology, Sanquin Research, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Förderung

  • Trombosestichting Nederland

Zitieren

APA

Noordermeer, T., Chemlal, S., Jansma, J. J., van der Vegte, V., Schutgens, R. E. G., Limper, M., de Groot, P. G., Meijers, J. C. M., & Urbanus, R. T. (2023). Anti–β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C. Journal of Thrombosis and Haemostasis, 21(9), 2509-2518. https://doi.org/10.1016/j.jtha.2023.05.024

Vancouver

Noordermeer T, Chemlal S, Jansma JJ, van der Vegte V, Schutgens REG, Limper M, et al. Anti–β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C. Journal of Thrombosis and Haemostasis. 2023;21(9):2509-2518. doi:10.1016/j.jtha.2023.05.024

BibTeX
@article{Noordermeer2023,
  author = {Noordermeer, Tessa and Chemlal, Soumaya and Jansma, Janna J and van der Vegte, Vossa and Schutgens, Roger E G and Limper, Maarten and de Groot, Philip G and Meijers, Joost C M and Urbanus, Rolf T},
  title = {Anti–β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2509--2518},
  doi = {10.1016/j.jtha.2023.05.024}
}
Kostenlos starten →